{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:02:33Z","timestamp":1781852553795,"version":"3.54.5"},"reference-count":65,"publisher":"Informa UK Limited","issue":"6","funder":[{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["PF-16-007"],"award-info":[{"award-number":["PF-16-007"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.2217\/fon-2020-0720","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T20:32:29Z","timestamp":1604349149000},"page":"711-722","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Nanotechnology-Based Platforms to Improve Immune Checkpoint Blockade Efficacy in Cancer Therapy"],"prefix":"10.1080","volume":"17","author":[{"given":"Deeksha G","family":"Lahori","sequence":"first","affiliation":[{"name":"School of Pharmacy,University of Sydney, \rSydney, \rNSW \r2006, \rAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-9722","authenticated-orcid":false,"given":"Pegah","family":"Varamini","sequence":"additional","affiliation":[{"name":"School of Pharmacy,University of Sydney, \rSydney, \rNSW \r2006, \rAustralia"},{"name":"The University of Sydney Nano Institute,University of Sydney, \rSydney, \rNSW \r2006, \rAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21442"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3673295"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.07.017"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1042\/CBI20090206"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.2217\/1750743X.1.1.83"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0609385"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.24.14322"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.09.026"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00923.x"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00662.x"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0329-9"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i20.2137"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0004"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-018-0133-y"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67313"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.04.014"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87415"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0127"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30607-1"},{"key":"e_1_3_2_22_1","first-page":"5","article-title":"CTLA-4 blockade in tumor models: an overview of preclinical and translational research","volume":"13","author":"Grosso JF","year":"2013","unstructured":"GrossoJF, Jure-KunkelMN. CTLA-4 blockade in tumor models: an overview of preclinical and translational research. Cancer Immun.13, 5 (2013).","journal-title":"Cancer Immun."},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri727"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160062"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082492"},{"key":"e_1_3_2_26_1","unstructured":"FDA Rubber-Stamps Bristol-Myers Squibb\u2019s Melanoma mAb | GEN - Genetic Engineering and Biotechnology News. (2019). www.genengnews.com\/topics\/drug-discovery\/fda-rubber-stamps-bristol-myers-squibbs-melanoma-mab\/"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicines5040114"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02100"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.7609"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104621"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200694"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603702"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14011"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.0703"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1586"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0278-7"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2015.10.009"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80005"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3237"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1566"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.12.030"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1087250"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.7150\/jbm.18877"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S146315"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2014.356"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-071811-150124"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2017.0052"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.08.005"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2013.09.011"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.434"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.6b09538"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12499"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.8b00040"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao1736"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9RA06678K"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.6b08152"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.10.013"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b06522"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.11"},{"issue":"21","key":"e_1_3_2_61_1","first-page":"7483","article-title":"Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity","volume":"63","author":"Santulli-Marotto S","year":"2003","unstructured":"Santulli-MarottoS, NairSK, RusconiC, SullengerB, GilboaE. Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. Cancer Res.63(21), 7483\u20137489 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00649"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2017.08.010"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2017.11.019"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01260"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.8b00204"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13193"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2020-0720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:46:45Z","timestamp":1719125205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2020-0720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.2217\/fon-2020-0720"],"URL":"https:\/\/doi.org\/10.2217\/fon-2020-0720","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}